Giuseppe Caruso, Gynecology Oncology Specialist at European Institute of Oncology, shared a post a post on X:
“2024: A Break through Year in Gynecologic Oncology.
With 6 new FDA-approved drugs/indications, we are entering a brighter future for patients battling gynecological malignancies.
Hope is stronger than ever.”
For more updates, follow OncoDaily.